Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Immunol. 2018 Apr 27;200(12):4012–4023. doi: 10.4049/jimmunol.1800112

Figure 2. Talin deficiency decreases Treg cell suppressive capacity.

Figure 2

(A–B) Percentages (n=6) (A) and numbers (n=10) (B) of splenic CD4+ T cells from Tln1fl/fl or Tln1fl/flFoxp3Cre mice expressing Foxp3. (C) Foxp3+ cells as a percentage of CD4+ T cells within tissues (blood, thymus, liver, lung and lymph node) derived from Tln1fl/fl or Tln1fl/flFoxp3Cre mice; n=6. Mice were perfused prior to isolation of cells from liver and lung. (D) Mean fluorescence intensity of Foxp3 from talin-deficient and wild-type Treg cells; n=7. (E) Expression of putative suppressor molecules on Treg cells from Tln1fl/fl or Tln1fl/flFoxp3Cre mice; displayed cells gated on CD4+Foxp3+ cells; n=6. (F) Suppression by sorted YFP+ Treg cells from Foxp3Cre or Tln1fl/flFoxp3Cre mice at decreasing Tconv:Treg cell ratios, measured at 72 hours. (G) Percentages of splenic Treg CD4+YFP+ cells expressing IFNγ, IL-17A and TNFα; n=6. Data are mean ± SEM and representative of at least 2 independent experiments. *, P < 0.05; **, P <0.01, *** P <0.005, unpaired Student’s t-test.

HHS Vulnerability Disclosure